3D-QSAR and Molecular Docking Studies on Design Anti-prostate Cancer Curcumin Analogues

作者: Xi Meng , Lianhua Cui , Fucheng Song , Mingyuan Luan , Junjie Ji

DOI: 10.2174/1573409914666181029123746

关键词:

摘要: Background Prostate cancer is one of the most common tumors in world and fifth leading cause male death. Although treatment localized androgen-dependent prostate has been successful, efficacy androgen-independent metastatic disease limited. Curcumin, a natural product, found to inhibit proliferation cells. Objective To design curcumin analogs with higher biological activity lower toxicity side effects for cancer. Methods In this study, three dimensional-quantitative structure relationship (3DQSAR) molecular docking studies were performed on 34 as anti-prostate compounds. We introduced OSIRIS Property Explorer predict drug-related properties newly designed Results The optimum CoMSIA model exhibited statistically significant results: cross-validated correlation coefficient q2 0.540 non-cross-validated R2 value 0.984. external predictive Rext 2 0.792. information structure-activity can be obtained from contour maps. addition, study compounds 3ZK6 protein target revealed important interactions between active amino acids. Conclusion Compound 28i may new type drug more promising development.

参考文章(42)
Ajay N. Jain, Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. Journal of Medicinal Chemistry. ,vol. 46, pp. 499- 511 ,(2003) , 10.1021/JM020406H
Estefanía Burgos-Morón, José Manuel Calderón-Montaño, Javier Salvador, Antonio Robles, Miguel López-Lázaro, The dark side of curcumin. International Journal of Cancer. ,vol. 126, pp. 1771- 1775 ,(2010) , 10.1002/IJC.24967
Zhuang Yu, Xianchao Li, Cuizhu Ge, Hongzong Si, Lianhua Cui, Hua Gao, Yunbo Duan, Honglin Zhai, 3D-QSAR modeling and molecular docking study on Mer kinase inhibitors of pyridine-substituted pyrimidines Molecular Diversity. ,vol. 19, pp. 135- 147 ,(2015) , 10.1007/S11030-014-9556-0
Jun-Ling Ji, Xian-Feng Huang, Hai-Liang Zhu, Curcumin and its Formulations: Potential Anti-Cancer Agents Anti-cancer Agents in Medicinal Chemistry. ,vol. 12, pp. 210- 218 ,(2012) , 10.2174/187152012800228733
Markus A. Lill, Multi-dimensional QSAR in drug discovery Drug Discovery Today. ,vol. 12, pp. 1013- 1017 ,(2007) , 10.1016/J.DRUDIS.2007.08.004
Marie-Hélène Teiten, François Gaascht, Serge Eifes, Mario Dicato, Marc Diederich, Chemopreventive potential of curcumin in prostate cancer. Genes and Nutrition. ,vol. 5, pp. 61- 74 ,(2010) , 10.1007/S12263-009-0152-3
Frans Debruyne, Hormonal therapy of prostate cancer. Seminars in Urologic Oncology. ,vol. 20, pp. 4- 9 ,(2002) , 10.1053/SURO.2002.35051
Ildiko Frank, John Feikema, Nick Constantine, Bruce Kowalski, Prediction of Product Quality from Spectral Data Using the Partial Least-Squares Method Journal of Chemical Information and Modeling. ,vol. 24, pp. 20- 24 ,(1984) , 10.1021/CI00041A602
Nicholas G. Zaorsky, Amy S. Harrison, Edouard J. Trabulsi, Leonard G. Gomella, Timothy N. Showalter, Mark D. Hurwitz, Adam P. Dicker, Robert B. Den, Evolution of advanced technologies in prostate cancer radiotherapy Nature Reviews Urology. ,vol. 10, pp. 565- 579 ,(2013) , 10.1038/NRUROL.2013.185